New HIV vaccine approach targets desirable immune cells
Thursday, September 1, 2011 - 17:00
in Health & Medicine
Researchers at Duke University Medical Center, Beth Israel Deaconess Medical Center and Harvard Medical School have demonstrated an approach to HIV vaccine design that uses an altered form of HIV's outer coating or envelope protein.